OLVIG
SNY icon

Oliver Lagore Vanvalin Investment Group’s Sanofi SNY Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-173
Closed -$9.28K – 862
2023
Q3 		$9.28K Buy
+173
New +$9.22K ﹤0.01% 451
2022
Q4 		– Sell
-20
Closed -$1K – 757
2022
Q3 		$1K Hold
20
– – ﹤0.01% 609
2022
Q2 		$1K Buy
+20
New +$1.06K ﹤0.01% 585

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's SNY Position: Q4 2023 in Review

Oliver Lagore Vanvalin Investment Group sold out of Sanofi (SNY) in Q4 2023, closing a stake of 173 shares — an estimated $9.28K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in SNY in Q2 2022 and held it in 3 quarters. The position peaked at $9.28K in Q3 2023. 708 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 173 Sanofi shares in Q4 2023, an estimated $9.28K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Sanofi in Q2 2022 and held it in 3 quarters.
  • Oliver Lagore Vanvalin Investment Group's Sanofi position peaked at $9.28K in Q3 2023.
  • 708 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2023, filed 31 Jan 2024.